Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SGX:T14)
Singapore flag Singapore · Delayed Price · Currency is SGD · Price in USD
3.200
-0.120 (-3.61%)
Mar 4, 2026, 4:59 PM SGT

SGX:T14 Ratios and Metrics

Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
5,2163,8704,1183,5474,1332,267
Market Cap Growth
37.78%-6.01%16.09%-14.17%82.27%29.44%
Enterprise Value
4,9013,8363,8913,1453,7151,941
Last Close Price
4.252.442.121.101.040.75
PE Ratio
8.049.2922.4221.1725.3216.93
PS Ratio
5.362.832.692.212.821.70
PB Ratio
3.192.643.332.792.991.88
P/TBV Ratio
3.302.753.562.963.162.00
P/FCF Ratio
33.9825.6540.4032.0528.0023.22
P/OCF Ratio
30.3622.3932.1326.9422.8516.68
EV/Sales Ratio
4.932.812.541.962.531.45
EV/EBITDA Ratio
26.3022.9722.0620.5824.9614.51
EV/EBIT Ratio
29.8026.5125.4624.1029.8217.40
EV/FCF Ratio
31.9325.4338.1728.4225.1719.88
Debt / Equity Ratio
0.000.010.050.040.010.01
Debt / EBITDA Ratio
0.020.040.360.340.060.06
Debt / FCF Ratio
0.020.050.620.470.060.09
Net Debt / Equity Ratio
-0.19-0.50-0.28-0.40-0.36-0.33
Net Debt / EBITDA Ratio
-1.71-4.37-1.95-3.38-3.35-2.94
Net Debt / FCF Ratio
-2.02-4.84-3.37-4.66-3.38-4.03
Asset Turnover
0.480.700.810.860.800.82
Inventory Turnover
1.312.673.093.382.762.61
Quick Ratio
1.361.871.511.711.811.85
Current Ratio
2.812.352.032.172.642.59
Return on Equity (ROE)
46.11%30.56%14.68%13.37%12.63%11.85%
Return on Assets (ROA)
4.92%4.61%5.03%4.37%4.23%4.27%
Return on Invested Capital (ROIC)
13.70%15.21%16.70%14.84%12.96%12.12%
Return on Capital Employed (ROCE)
9.70%9.70%11.70%9.80%8.90%9.00%
Earnings Yield
12.44%10.77%4.46%4.72%3.95%5.91%
FCF Yield
2.94%3.90%2.48%3.12%3.57%4.31%
Dividend Yield
20.63%9.81%11.22%19.88%10.18%8.14%
Payout Ratio
28.19%45.33%88.91%44.96%30.17%35.15%
Buyback Yield / Dilution
0.33%-0.07%0.71%-0.94%0.04%0.37%
Total Shareholder Return
20.96%9.74%11.93%18.94%10.22%8.51%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.